| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase I/II trial of tremelimumab in patients with metastatic melanoma. | J Clin Oncol | 2009 | 2.53 |
| 2 | Phase I study of JM-216 (an oral platinum analogue) in combination with paclitaxel in patients with advanced malignancies. | Invest New Drugs | 2002 | 0.78 |